January 14, 2025

What Makes Skin Look Dry? Study Reveals

The perception of skin hydration relies on visual cues including lightness and color distribution.

Conexiant

January 14, 2025

Novel Focal Point Technology Controls Laser Treatment Depth

"The focused ring beam spares an island of superficial tissue," researchers report in a new study demonstrating precise depth control in laser treatments while protecting the epidermis.

Conexiant

January 07, 2025

Patient Insights on HRQOL in Chronic GVHD

Explore how cutaneous graft-versus-host disease impacts patients’ quality of life across physical, psychological, and social domains.

Conexiant

January 02, 2025

Glutamatergic Drugs Reduce OCD Symptoms, Study Shows

A meta-analysis suggests that glutamatergic medications significantly reduce obsessive-compulsive disorder symptoms but calls for further research due to study limitations.

Conexiant

December 30, 2024

Nutrafol Safety Signal Emerges in Case Study

A previously healthy 26-year-old developed severe liver injury after using Nutrafol, with a biopsy confirming marked necroinflammatory damage with complete resolution upon discontinuation.

Conexiant

September 17, 2024

Can Hair Dye Cause Retinopathy?

Aromatic amines may cause long-term RPE dysfunction

Conexiant

July 26, 2024

Healing and Owing: U.S. Health Workers' $150 Billion Debt Dilemma

A new study exposes the alarming levels of medical and educational debt burdening U.S. health care workers, with debt disproportionately affecting women, Black workers, and those in lower-paying fields.

Conexiant

August 05, 2024

Global Study Reveals Body Appreciation Trends

A recent study revealed significant cross-cultural differences in body appreciation among women from six countries, with Black Nigerian women reporting the highest levels and White Western women reporting the lowest.

Conexiant

August 26, 2024

High Relapse Rates in Severe Alopecia Areata After Baricitinib Withdrawal

A recent JAMA Dermatology study reveals that over 80% of patients with severe alopecia areata may experience relapse within 152 weeks post-withdrawal, highlighting the need for ongoing maintenance therapy for sustained hair regrowth.

Conexiant